China Wants ‘non-discriminatory’ Treatment Of Huawei, As Survey Says 76 Per Cent Of Canadians Want The Tech Company Banned From 5G

China Wants 'non-discriminatory' Treatment Of Huawei, As Survey Says 76 Per Cent Of Canadians Want The Tech Company Banned From 5G

China’s foreign ministry has called on Canada to be “non-discriminatory” towards Huawei Technologies Co. and other mainland firms after a survey found more than three-quarters of Canadians want the tech giant banned from the country’s 5G networks.

The Nanos poll was conducted for The Globe and Mail newspaper after China released two Canadians whose detention for almost three years was viewed by Ottawa as hostage diplomacy.

Michael Kovrig and Michael Spavor were released last month on the same day as Huawei executive Meng Wanzhou, who was being held under partial house arrest in Vancouver until she struck a deal with the US that resulted in prosecutors dropping their request for her extradition on fraud charges.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you

Read More Read More

Lymphedema: Symptoms, Treatment, and More

Leer esta página en español

Lymphedema is abnormal swelling that can develop in the arm, hand, breast, or torso as a side effect of breast cancer surgery and/or radiation therapy. Lymphedema can appear in some people during the months or even years after treatment ends.

Lymph is a thin, clear fluid that circulates throughout the body to remove wastes, bacteria, and other substances from tissues. Edema is the buildup of excess fluid. So lymphedema occurs when too much lymph collects in any area of the body. If lymphedema develops in people who’ve been treated for breast cancer, it usually occurs in the arm and hand, but sometimes it affects the breast, underarm, chest, trunk, and/or back.

Lymphedema usually develops gradually, and you may feel an unusual sensation — such as tingling or numbness —

Read More Read More

Merck oral Covid treatment reduces risk of hospitalization, death by half for some patients

Merck and Ridgeback Biotherapeutics said Friday they’ve developed a drug that reduces the risk of hospitalization or death by around 50% for patients with mild or moderate cases of Covid.

The companies plan to seek emergency authorization for the antiviral Covid treatment after the medicine showed “compelling results” in clinical trials.

The drug, molnupiravir, is administered orally and works by inhibiting the replication of the coronavirus inside the body.

An interim analysis of a phase 3 study found that 7.3% of patients treated with molnupiravir were hospitalized within 29 days. Of the patients who received a placebo, 14.1% were hospitalized or died by day 29. No deaths were reported in patients who were given molnupiravir within the 29-day period, while eight deaths were reported in placebo-treated patients.

“The news of the efficacy of this particular antiviral is obviously very good news,” White House chief medical advisor Dr. Anthony Fauci said

Read More Read More

Gov. Cox and Lt. Gov. Henderson order paid leave for mental health treatment and education

SALT LAKE CITY (Oct. 12, 2021) — Gov. Spencer J. Cox and Lt. Gov. Deidre Henderson issued an executive order granting all state executive branch employees four (4) hours of administrative leave to address mental health issues. 

A recent CDC survey found that nearly 41% of respondents reported an adverse mental or behavioral health condition, such as anxiety, depression, loneliness, or increased substance use. In addition, a Society for Human Resource Management survey found that work-related concerns left more than 40% of employees feeling hopeless, burned out or exhausted as they grapple with lives altered by the COVID-19 pandemic. Yet, 37% of employees said they haven’t done anything to cope with depression-related symptoms. 

“As leaders, it is our responsibility to transform the ways we think about, talk about and address all forms of mental health challenges,” Gov. Cox said in a video message to state employees. “We

Read More Read More

New records reveal the cost of Pa.’s failure to clarify rules around addiction treatment and marijuana | News

Spotlight PA is an independent, nonpartisan newsroom powered by The Philadelphia Inquirer in partnership with PennLive/The Patriot-News, TribLIVE/Pittsburgh Tribune-Review, and WITF Public Media. Sign up for our free newsletters.

Harrisburg, Pa. — The failure by Gov. Tom Wolf’s administration to clarify federal rules around addiction treatment funding and medical marijuana caused even greater confusion and serious consequences than previously disclosed, a follow-up Spotlight PA investigation has found.

In September 2019, the federal agency that pays out hundreds of millions of dollars to Pennsylvania each year to combat the addiction crisis began warning recipients not to permit “marijuana use for the purposes of treating substance use or mental disorders.” That was particularly serious here, in one of the few states to endorse cannabis as a treatment option for opioid use disorder.

The rules weren’t as restrictive as they might have seemed, however. A few months later — on Jan. 1,

Read More Read More

TMJ disorders – Diagnosis and treatment


Your doctor or dentist will discuss your symptoms and examine your jaw. He or she will probably:

  • Listen to and feel your jaw when you open and close your mouth
  • Observe the range of motion in your jaw
  • Press on areas around your jaw to identify sites of pain or discomfort

If your doctor or dentist suspects a problem, you may need:

  • Dental X-rays to examine your teeth and jaw
  • CT scan to provide detailed images of the bones involved in the joint
  • MRI to reveal problems with the joint’s disk or surrounding soft tissue

TMJ arthroscopy is sometimes used in the diagnosis of a TMJ disorder. During TMJ arthroscopy, your doctor inserts a small thin tube (cannula) into the joint space, and a small camera (arthroscope) is then inserted to view the area and to help determine a diagnosis.

More Information


In some

Read More Read More

Treatment | Living with HIV | HIV Basics | HIV/AIDS

What is HIV treatment?

HIV treatment involves taking medicine that reduces the amount of HIV in your body.

  • HIV medicine is called antiretroviral therapy (ART).
  • There is no effective cure for HIV. But with proper medical care, you can control HIV.
  • Most people can get the virus under control within six months.
  • Taking HIV medicine does not prevent transmission of other sexually transmitted diseases.
When should I start treatment?

Start Treatment As Soon As Possible After Diagnosis

  • HIV medicine is recommended for all people with HIV, regardless of how long they’ve had the virus or how healthy they are.
  • Talk to your health care provider about any medical conditions you may have or any other medicines you are taking.
  • Let your health care provider know if you or your partner is pregnant or thinking about getting pregnant. They will determine the right type of HIV medicine that can help prevent
Read More Read More

Immunotherapy for Breast Cancer: Keytruda, Tecentriq, and More

Immunotherapy medicines use the power of your body’s immune system to attack cancer cells.

There are several immunotherapy medicines approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer.

Immune checkpoint inhibitors to treat breast cancer are:

  • Jemperli (chemical name: dostarlimab-gxly)
  • Keytruda (chemical name: pembrolizumab)

Jemperli is used to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available. Fewer than 1% of breast cancers have the dMMR biomarker.

Keytruda is used in combination with chemotherapy to treat unresectable
locally advanced or metastatic triple-negative, PD-L1-positive breast
cancer. Unresectable means that it can’t be removed with surgery.

Keytruda also is used in combination with chemotherapy before surgery, and then on its own after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence

Read More Read More

Lymphedema & Exercise |

Leer esta página en español

Several research studies have found that a program of gradually increasing exercise supervised by a certified lymphedema therapist — meaning you start gently and intensify slowly over time — is not likely to increase the risk of lymphedema. This is also the recommendation made in the National Lymphedema Network’s Position Statement on Exercise. Some experts believe that exercise may even play a role in rehabilitating the arm so that it can better withstand the day-to-day stresses that can lead to lymphedema.

“I believe that cardiac rehabilitation is a great analogy for this,” says Kathryn Schmitz, Ph.D., MPH, professor in the Division of Clinical Epidemiology at the University of Pennsylvania. “Let’s say you have damage to the heart muscle because of a heart attack. Well, those damaged cells are never coming back. But the more you strengthen the rest of your heart through exercise, the smaller

Read More Read More

Selective Estrogen Receptor Modulators (SERMs)

Leer esta página en español

Selective estrogen receptor modulators, called SERMs for short, block the effects of estrogen in the breast tissue. SERMs work by sitting in the estrogen receptors in breast cells. If a SERM is in the estrogen receptor, there is no room for estrogen and it can’t attach to the cell. If estrogen isn’t attached to a breast cell, the cell doesn’t receive estrogen’s signals to grow and multiply.

Cells in other tissues in the body, such as bones and the uterus, also have estrogen receptors. But each estrogen receptor has a slightly different structure, depending on the kind of cell it is in. So breast cell estrogen receptors are different from bone cell estrogen receptors and both of those estrogen receptors are different from uterine estrogen receptors. As their name says, SERMs are “selective” — this means that a SERM that blocks estrogen’s action in breast

Read More Read More